Mast Cells, Mastocytosis, and Related Disorders
The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
This article provides an overview of recent developments concerning the physiology and pathobiology of mast cells and discusses current diagnostic and therapeutic approaches to mast-cell disorders, with an emphasis on mastocytosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Well-recognized symptoms of systemic MCA include, among others, acute urticaria, flushing, abdominal cramping, diarrhea, hypotensive syncope or near syncope and tachycardia (Table 3) (1-3,26-28,31).”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“the severity of MCA correlates with the extent of mediator release from MC during an anaphylactic reaction.”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“MCA symptoms are caused by several different vasoactive and pro-inflammatory mediators released from MC when these cells are activated by an allergen via IgER cross-linking or other mechanisms (1-5,29-31).”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“However, there are insuf fi cient data to demonstrate their clinical utility in the diagnosis of MCA and MCAS.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [13]
In the citing paper
“Severe forms of MCA (anaphylaxis) are usually observed in patients with IgE-dependent allergies and those with clonal MC disorders.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [13]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108
Self-citationOmalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Maurer, M., Rosén, K., Hsieh, H.-J., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215372 · Cited by 1,105
Galli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Naclerio, R. M. (2003) · Cited by 985
Mast cell-orchestrated immunity to pathogens
Abraham, S. N., & St. John, A. L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2782 · Cited by 837
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationThe diagnosis and management of anaphylaxis practice parameter: 2010 Update
Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., Lang, D. M., Bernstein, D. I., Bernstein, J. A., Burks, A. W., Feldweg, A. M., Fink, J. N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.022 · Cited by 739
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
Galli, S. J., Grimbaldeston, M., & Tsai, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2327 · Cited by 738
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Self-citationValent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationWheatley, L. M., & Togias, A. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1412282 · Cited by 606
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Lim, K.-H., Tefferi, A., Lasho, T. L., Finke, C., Patnaik, M., Butterfield, J. H., McClure, R. F., Li, C.-Y., & Pardanani, A. (2009) · Blood · doi:10.1182/blood-2009-02-205237 · Cited by 588
Brockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523
Diagnostic Value of Tryptase in Anaphylaxis and Mastocytosis
Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477
Skokos, D., Botros, H. G., Demeure, C., Morin, J., Peronet, R., Birkenmeier, G., Boudaly, S., & Mécheri, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3037 · Cited by 443
Differential release of mast cell mediators and the pathogenesis of inflammation
Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P., & Kalogeromitros, D. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00519.x · Cited by 425
Self-citationBodemer, C., Hermine, O., Palmérini, F., Yang, Y., Grandpeix-Guyodo, C., Leventhal, P. S., Hadj-Rabia, S., Nasca, L., Georgin-Lavialle, S., Cohen-Akenine, A., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.281 · Cited by 397
Mast cell activation syndrome: Proposed diagnostic criteria
Akin, C., Valent, P., & Metcalfe, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.035 · Cited by 327
Self-citationTheoharides, T. C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A., Alysandratos, K.-D., Kalogeromitros, D., Asadi, S., Stavrianeas, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000803107 · Cited by 318
Self-citationA novel form of mastocytosis associated with a transmembrane c‐kit mutation and response to imatinib
Akin, C., Fumo, G., Yavuz, A. S., Lipsky, P. E., Neckers, L., & Metcalfe, D. D. (2004) · Blood · doi:10.1182/blood-2003-11-3816 · Cited by 313
Self-citationEscribano, L., Álvarez-Twose, I., Sánchez-Muñoz, L., Garcia-Montero, A., Núñez, R., Almeida, J., Jara-Acevedo, M., Teodósio, C., García-Cosío, M., Bellas, C., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.003 · Cited by 292
Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W. S., Sugimoto, K., Cetrulo, C. L., & Theoharides, T. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7665 · Cited by 285
Self-citationShah, N. P., Lee, F. Y., Luo, R., Jiang, Y., Donker, M., & Akin, C. (2006) · Blood · doi:10.1182/blood-2005-10-3969 · Cited by 273
Self-citationMast cells enhance T cell activation: Importance of mast cell-derived TNF
Nakae, S., Suto, H., Kakurai, M., Sedgwick, J. D., Tsai, M., & Galli, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501912102 · Cited by 253
Cladribine therapy for systemic mastocytosis
Kluin-Nelemans, H. C. (2003) · Blood · doi:10.1182/blood-2003-05-1699 · Cited by 248
Akin, C., Scott, L. M., Kocabas, C. N., Kushnir-Sukhov, N., Brittain, E., Noel, P., & Metcalfe, D. D. (2007) · Blood · doi:10.1182/blood-2006-06-028100 · Cited by 240
Self-citationEpidemiology of systemic mastocytosis in Denmark
Cohen, S. S., Skovbo, S., Vestergaard, H., Kristensen, T., Møller, M., Bindslev‐Jensen, C., Fryzek, J. P., & Broesby‐Olsen, S. (2014) · British Journal of Haematology · doi:10.1111/bjh.12916 · Cited by 234
IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells
Kandere-Grzybowska, K., Letourneau, R., Kempuraj, D., Donelan, J., Poplawski, S., Boucher, W., Athanassiou, A., & Theoharides, T. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4830 · Cited by 233
Self-citationMast Cells as Sensors of Cell Injury through IL-33 Recognition
Enoksson, M., Lyberg, K., Möller-Westerberg, C., Fallon, P. G., Nilsson, G., & Lunderius-Andersson, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003383 · Cited by 218
Bryniarski, K., Ptak, W., Jayakumar, A., Püllmann, K., Caplan, M. J., Chairoungdua, A., Lu, J., Adams, B. D., Sikora, E., Nazimek, K., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.048 · Cited by 215
Kristensen, T., Vestergaard, H., & Møller, M. B. (2011) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.10.004 · Cited by 208
Diagnosis and Treatment of Cutaneous Mastocytosis in Children: Practical Recommendations
Castells, M., Metcalfe, D. D., & Escribano, L. (2011) · American Journal of Clinical Dermatology · doi:10.2165/11588890-000000000-00000 · Cited by 191
Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
Ustun, C., Reiter, A., Scott, B. L., Nakamura, R., Damaj, G., Kreil, S., Shanley, R., Hogan, W. J., Perales, M.-A., Shore, T., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.2018 · Cited by 190
Self-citationChapter 3 New Insights on Mast Cell Activation via the High Affinity Receptor for IgE
Rivera, J., Fierro, N. A., Olivera, A., & Suzuki, R. (2008) · Advances in Immunology · doi:10.1016/s0065-2776(08)00403-3 · Cited by 180
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis
Carter, M. C., Robyn, J. A., Bressler, P. B., Walker, J. C., Shapiro, G. G., & Metcalfe, D. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.032 · Cited by 172
Yavuz, A. S., Lipsky, P. E., Yavuz, S., Metcalfe, D. D., & Akin, C. (2002) · Blood · doi:10.1182/blood-2002-01-0203 · Cited by 169
Self-citationCromolyn sodium in the management of systemic mastocytosis
Horan, R. F., Sheffer, A. L., & Austen, K. F. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90067-e · Cited by 164
Alvarez‐Twose, I., Vañó‐Galván, S., Sánchez‐Muñoz, L., Morgado, J. M., Matito, A., Torrelo, A., Jaén, P., Schwartz, L. B., Orfao, A., & Escribano, L. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02812.x · Cited by 163
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis
Erben, P., Schwaab, J., Metzgeroth, G., Horny, H.-P., Jawhar, M., Sotlar, K., Fabarius, A., Teichmann, M., Schneider, S., Ernst, T., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-013-1964-1 · Cited by 162
Molecular targets on mast cells and basophils for novel therapies
Harvima, I. T., Levi‐Schaffer, F., Dráber, P., Friedman, S., Polakovičová, I., Gibbs, B. F., Blank, U., Nilsson, G. P., & Maurer, M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.03.007 · Cited by 151
TNF Trafficking to Human Mast Cell Granules: Mature Chain-Dependent Endocytosis
Olszewski, M. B., Groot, A. J., Dastych, J., & Knol, E. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5701 · Cited by 151
The mastocytosis society survey on mast cell disorders: patient experiences and perceptions
Jennings, S., Russell, N., Jennings, B., Slee, V., Sterling, L., Castells, M., Valent, P., & Akin, C. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2013.09.004 · Cited by 143
Self-citationDonelan, J., Boucher, W., Papadopoulou, N., Lytinas, M., Papaliodis, D., Dobner, P., & Theoharides, T. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602210103 · Cited by 142
Self-citationThe novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
Weng, Z., Patel, A. B., Panagiotidou, S., & Theoharides, T. C. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.032 · Cited by 141
Self-citationMast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function
Dudeck, A., Suender, C. A., Kostka, S. L., von Stebut, E., & Maurer, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201040994 · Cited by 140
Evidence questioning cromolyn's effectiveness and selectivity as a ‘mast cell stabilizer' in mice
Oka, T., Kalesnikoff, J., Starkl, P., Tsai, M., & Galli, S. J. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.116 · Cited by 131
Sonneck, K., Florian, S., Müllauer, L., Wimazal, F., Födinger, M., Sperr, W. R., & Valent, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000096442 · Cited by 129
Self-citationDifferential Release of Mast Cell Interleukin-6 Via c-kit
Gagari, E., Tsai, M., Lantz, C. S., Fox, L. G., & Galli, S. J. (1997) · Blood · doi:10.1182/blood.v89.8.2654 · Cited by 125
The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
Drube, S., Heink, S., Walter, S., Löhn, T., Grusser, M., Gerbaulet, A., Berod, L., Schons, J., Dudeck, A., Freitag, J., et al. (2010) · Blood · doi:10.1182/blood-2009-10-247411 · Cited by 124
Zanotti, R., Lombardo, C., Passalacqua, G., Caimmi, C., Bonifacio, M., De Matteis, G., Perbellini, O., Rossini, M., Schena, D., Busa, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.035 · Cited by 123
Zhang, B., Asadi, S., Weng, Z., Sismanopoulos, N., & Theoharides, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049767 · Cited by 121
Self-citationHoermann, G., Gleixner, K. V., Dinu, G. E., Kundi, M., Greiner, G., Wimazal, F., Hadzijusufovic, E., Mitterbauer, G., Mannhalter, C., Valent, P., et al. (2014) · Allergy · doi:10.1111/all.12409 · Cited by 105
Self-citationGodt, O., Proksch, E., Streit, V., & Christophers, E. (2009) · Dermatology · doi:10.1159/000245681 · Cited by 104
Mast cells as therapeutic target in cancer
Ribatti, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.056 · Cited by 94
Gastrointestinal manifestations in mastocytosis: A study of 83 patients
Sokol, H., Georgin‐Lavialle, S., Canioni, D., Barète, S., Damaj, G. L., Soucie, E. L., Bruneau, J., Chandesris, M., Suárez, F., Launay, J., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.026 · Cited by 93
Krauth, M. ‐., Mirkina, I., Herrmann, H., Baumgartner, C., Kneidinger, M., & Valent, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03353.x · Cited by 89
Self-citationvan Anrooij, B., van der Veer, E., de Monchy, J. G. R., van der Heide, S., Kluin-Nelemans, J. C., van Voorst Vader, P. C., van Doormaal, J. J., & Oude Elberink, J. N. G. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1578 · Cited by 89
Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine
Pardanani, A. D., Hoffbrand, A. V., Butterfield, J. H., & Tefferi, A. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00185-1 · Cited by 87
Novel Identified Receptors on Mast Cells
Migalovich-Sheikhet, H., Friedman, S., Mankuta, D., & Levi-Schaffer, F. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00238 · Cited by 87
Mechanisms of Acute Coronary Syndromes
Gómez-Arbeláez, D., & López-Jaramillo, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1307806 · Cited by 87
The role of IL-17-secreting mast cells in inflammatory joint disease
Kenna, T., & Brown, M. A. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.205 · Cited by 86
Rottem, M., & Mekori, Y. A. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.05.001 · Cited by 78
Moura, D. S., Sultan, S., Georgin-Lavialle, S., Barete, S., Lortholary, O., Gaillard, R., & Hermine, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039468 · Cited by 75
The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis
Teodósio, C., Mayado, A., Sánchez‐Muñoz, L., Morgado, J. M., Jara‐Acevedo, M., Álvarez‐Twöse, I., García‐Montero, A. C., Matito, A., Caldas, C., Escribano, L., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ru0614-296r · Cited by 75
Vieira dos Santos, R., Magerl, M., Martus, P., Zuberbier, T., Church, M. K., Escribano, L., & Maurer, M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09516.x · Cited by 67
IL-33 is a mediator rather than a trigger of the acute allergic response in humans
Fux, M., Pecaric-Petkovic, T., Odermatt, A., Hausmann, O. V., Lorentz, A., Bischoff, S. C., Virchow, J. C., & Dahinden, C. A. (2013) · Allergy · doi:10.1111/all.12309 · Cited by 64
Ravi, A., Butterfield, J., & Weiler, C. R. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.06.011 · Cited by 63
Omalizumab for Chronic Urticaria
Maurer, M., Rosén, K. E., & Hsieh, H.-J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1305687 · Cited by 53
Neuropsychological Features of Adult Mastocytosis
Moura, D. S., Georgin‐Lavialle, S., Gaillard, R., & Hermine, O. (2014) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2014.02.001 · Cited by 49
Increased leukotriene E4 excretion in systemic mastocytosis
Butterfield, J. H. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.03.003 · Cited by 42
Alevizos, M., Karagkouni, A., Vasiadi, M., Sismanopoulos, N., Makris, M. P., Kalogeromitros, D. C., & Theoharides, T. C. (2013) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.08.025 · Cited by 40
Self-citationIn Vitro Inhibition of Human Conjunctival Mast-Cell Degranulation by Ketotifen
Schoch, C. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803762718132 · Cited by 37
Theoharides, T. C., Petra, A. I., Stewart, J. M., Tsilioni, I., Panagiotidou, S., & Akin, C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.023 · Cited by 29
Self-citationNeurologic symptoms and diagnosis in adults with mast cell disease
Smith, J. H., Butterfield, J. H., Pardanani, A. D., DeLuca, G. C., & Cutrer, F. M. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.05.002 · Cited by 29
Clemons, A., Vasiadi, M., Kempuraj, D., Kourelis, T., Vandoros, G., & Theoharides, T. C. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182196e50 · Cited by 25
Self-citationAbnormal bone marrow histopathology in paediatric mastocytosis
Carter, M. C., Metcalfe, D. D., Clark, A. S., Wayne, A. S., & Marić, I. (2014) · British Journal of Haematology · doi:10.1111/bjh.13231 · Cited by 21
Research works printed but not linked: 3
- Kounis NG, 2013, N Engl J Med, 369, 883
- Zanotti R, 2015, J Allergy Clin Immunol
- Ribatti D, 2015, Eur J Pharmacol
Cited by
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Valent, P., Akin, C., & Metcalfe, D. D. (2017) · Blood · doi:10.1182/blood-2016-09-731893 · Cited by 592
Self-citationHartmann, K., Escribano, L., Grattan, C., Brockow, K., Carter, M. C., Alvarez-Twose, I., Matito, A., Broesby-Olsen, S., Siebenhaar, F., Lange, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.034 · Cited by 394
Self-citationAnaphylaxis: A 2023 practice parameter update
Golden, D. B. K., Wang, J., Waserman, S., Akin, C., Campbell, R. L., Ellis, A. K., Greenhawt, M., Lang, D. M., Ledford, D. K., Lieberman, J., et al. (2024) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.09.015 · Cited by 347
Self-citationInteractions between mesenchymal stem cells and the immune system
Li, N., & Hua, J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2473-5 · Cited by 338
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Valent, P., Akin, C., Hartmann, K., Alvarez-Twose, I., Brockow, K., Hermine, O., Niedoszytko, M., Schwaab, J., Lyons, J. J., Carter, M. C., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000646 · Cited by 317
Self-citation
Metadata
- Authors
- Theoharides, T. C., Valent, P., & Akin, C.
- Affiliations
- Tufts University (US)
- Ludwig Boltzmann Institute for Hematology and Oncology (AT)
- Brigham and Women's Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-07-09
- Volume
- 373
- Issue
- 2
- Pages
- 163-172
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W809016622
- Cited by
- 518
- References
- 77
- Citations by year
- 2026: 34 · 2025: 29 · 2024: 37 · 2023: 41 · 2022: 44 · 2021: 61 · 2020: 59 · 2019: 53 · 2018: 47 · 2017: 50 · 2016: 45 · 2015: 17
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- mast cells, mastocytosis, mast cell disease, diagnosis, treatment
- MeSH terms
- Algorithms, Diagnosis, Differential, Epinephrine, Histamine H1 Antagonists, Humans, Mast Cells, Mastocytosis, Leukotriene Antagonists, Protein Kinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.